Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Common Medication Deferral Lists vs
While Retatrutide makes waves with its quad-agonist profile, Survodutide operates as a dual-agonist, specifically targeting both the GLP-1 and glucagon receptors
For patients currently using retatrutide through research channels, transitioning from other GLP-1 medications requires careful dose mapping and expectation management regarding treatment duration
A physician-guided plan allows the medication and dose to be adjusted over time
US$ 20.63
US$ 25.26
US$ 22.18
US$ 24.24
US$ 28.27
US$ 24.01
